Cited by 16Blood Pressure and Hypertension StudiesClinical practice guidelines implementationHealth Promotion and Cardiovascular Prevention

Use of risk assessment to guide decision-making for blood pressure management in the primary prevention of cardiovascular disease: a scientific statement from the American Heart Association and American College of Cardiology

Khan, Sadiya S., Lloyd-Jones, Donald M., Abdalla, Marwah, Bello, Natalie A., Blyler, Ciantel A., Carter, Jocelyn, Commodore-Mensah, Yvonne, Ferdinand, Keith C. +9 more·2025·JACC

Abstract

Risk assessment plays a central role in the primary prevention of cardiovascular disease. The 2017 High Blood Pressure Clinical Practice Guideline incorporated quantitative risk assessment for the first time to guide the initiation of antihypertensive drug therapy and recommended calculation of 10-year risk of atherosclerotic cardiovascular disease with the Pooled Cohort Equations. Although the 2025 High Blood Pressure Guideline reaffirmed this overarching paradigm for risk-based initiation of antihypertensive drug therapy, it updated the recommended risk model to the Predicting Risk of Cardiovascular Disease Events equations, which estimate 10-year risk of total cardiovascular disease (including atherosclerotic cardiovascular disease and heart failure), and defined a new risk threshold for initiation of antihypertensive therapy in patients with stage 1 hypertension. This American Heart Association/American College of Cardiology scientific statement summarizes the rationale to recommend the use of the Predicting Risk of Cardiovascular Disease Events equations, the evidence base for the new threshold of 10-year risk of cardiovascular disease of ≥7.5%, and the population-level implications of these revised recommendations. This scientific statement also offers practical advice for implementing risk assessment as the first step in the comprehensive approach to hypertension management with shared decision-making between patients and clinicians. Remaining gaps in awareness and tre…

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2025.08.001

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Khan, S. S., Lloyd-Jones, D. M., Abdalla, M., Bello, N. A., Blyler, C. A., Carter, J., Commodore-Mensah, Y., Ferdinand, K. C., Johnson, H. M., Jones, D., Khera, A., Muntner, P., Schott, S., Shimbo, D., Smith, S. C., Taler, S. J., & Yang, E.
Venue
JACC
Publisher
Elsevier BV
Published
2025-11
Volume
86
Issue
18
Pages
1539-1559
ISSN
0735-1097 (ISSN-L)
OpenAlex
W4413785197
Cited by
16
References
16
Citations by year
2026: 14 · 2025: 2
FWCI
11.11
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
quantitative risk assessment, blood pressure control, hypertension, primary prevention of cardiovascular disease, antihypertensive therapy initiation, Pooled Cohort Equations, stage 1 hypertension, shared decision-making, electronic health record decision support, guideline implementation
MeSH terms
Clinical Decision-Making, American Heart Association, Antihypertensive Agents, Blood Pressure, Cardiology, Cardiovascular Diseases, Humans, Hypertension, Primary Prevention, United States, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review